|
RNGTT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.96049999754567E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.12169999966616E-07 |
| Normal-vs-Stage2 |
1.40839999995812E-06 |
| Normal-vs-Stage3 |
8.84069994988579E-09 |
| Normal-vs-Stage4 |
1.72919999985588E-07 |
| Stage1-vs-Stage2 |
2.989000E-01 |
| Stage1-vs-Stage3 |
2.502200E-01 |
| Stage1-vs-Stage4 |
1.488020E-01 |
| Stage2-vs-Stage3 |
8.709400E-01 |
| Stage2-vs-Stage4 |
7.805400E-01 |
| Stage3-vs-Stage4 |
6.211800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.32539999665138E-08 |
| Normal-vs-AfricanAmerican |
3.793500E-02 |
| Normal-vs-Asian |
7.73789999963803E-07 |
| Caucasian-vs-AfricanAmerican |
1.126220E-02 |
| Caucasian-vs-Asian |
8.627600E-01 |
| AfricanAmerican-vs-Asian |
7.157100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.65979999031418E-09 |
| Normal-vs-Female |
4.43589999954419E-07 |
| Male-vs-Female |
2.385800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64569999999897E-06 |
| Normal-vs-Age(41-60Yrs) |
1.61690000277659E-08 |
| Normal-vs-Age(61-80Yrs) |
5.59739999905773E-08 |
| Normal-vs-Age(81-100Yrs) |
5.995700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.878410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.354200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.465000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.024400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.914000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.532400E-01 |
| Classical-VS-Follicular |
6.987000E-04 |
| Classical-VS-Other |
5.727700E-02 |
| Classical-VS-Normal |
4.54329999999281E-06 |
| Tall-VS-Follicular |
3.621600E-01 |
| Tall-VS-Other |
2.391200E-01 |
| Tall-VS-Normal |
8.2436000000019E-05 |
| Follicular-VS-Other |
4.941800E-01 |
| Follicular-VS-Normal |
3.98859945072161E-10 |
| Other-VS-Normal |
1.435990E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08740000337448E-08 |
| Normal-vs-N1 |
3.74190000096419E-08 |
| N0-vs-N1 |
5.430600E-01 |
|
|
